Level Biotechnology Inc.
TWO: 3118.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chun Long Qiu
- Employees
- 132
- Headquarters
- New Taipei City, Taiwan
- IPO year
- 2008
- Market cap
- NT$1.1B
- Website
- https://www.level.com.tw
Loading 3118…
Loading profile data…Frequently asked questions about 3118
What does Level Biotechnology Inc. (3118.TWO) do?
Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It also markets and distributes biomedical precision equipment. In addition, the company provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production...
Where does 3118.TWO trade?
Level Biotechnology Inc. (3118.TWO) trades on the Taipei Exchange.
What sector is 3118.TWO in?
Level Biotechnology Inc. (3118.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Level Biotechnology Inc.?
Chun Long Qiu is the chief executive officer of Level Biotechnology Inc. (3118.TWO).
Where is Level Biotechnology Inc. headquartered?
Level Biotechnology Inc. is headquartered in Taiwan.
Does 3118.TWO pay a dividend?
Yes — Level Biotechnology Inc. (3118.TWO) paid a trailing twelve-month dividend of TWD 1.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 3118.TWO go public?
Level Biotechnology Inc. (3118.TWO) completed its initial public offering in 2008.